Decitabine
Decitabine, sold under the brand name Dacogen, acts as a nucleic acid synthesis inhibitor. ... It is a medication for the treatment of myelodysplastic syndromes, ... ,由 E Jabbour 著作 · 2008 · 被引用 188 次 — Decitabine (5-aza-2′-deoxycytidine) is a hypomethylating agent with a dual mechanism of action: reactivation of silenced genes and differentiation at low ... ,Drug Type: Decitabine is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Decitabine is classified as an antimetabolite and a ... ,由 B Hackanson 著作 · 2014 · 被引用 37 次 — Besides 5-azacytidine (azacitidine, Vidaza®), 5-aza-2'-deoxycytidine (decitabine, Dacogen®) is the most widely used inhibitor of DNA methylation, ... ,由 X Feng 著作 · 2019 · 被引用 3 次 — However, the application of decitabine in myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) has not been fully examined. Thus, our study aimed ... ,Decitabine is a chemotherapeutic pyrimidine nucleoside analogue used for the treatment of myelodysplastic syndromes (MDS) by inducing DNA hypomethylation ... ,In preclinical studies in mice and rats, decitabine was teratogenic, fetotoxic, and embryotoxic. If this drug is used during pregnancy, or if a patient becomes ... ,Decitabine (NSC 127716) is an orally active deoxycytidine analogue antimetabolite and a DNA methyltransferase inhibitor. Decitabine incorporates into DNA in ...
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 Decitabine 相關參考資料
Decitabine - Wikipedia
Decitabine, sold under the brand name Dacogen, acts as a nucleic acid synthesis inhibitor. ... It is a medication for the treatment of myelodysplastic syndromes, ... https://en.wikipedia.org Evolution of Decitabine Development - NCBI
由 E Jabbour 著作 · 2008 · 被引用 188 次 — Decitabine (5-aza-2′-deoxycytidine) is a hypomethylating agent with a dual mechanism of action: reactivation of silenced genes and differentiation at low ... https://www.ncbi.nlm.nih.gov Decitabine - Drug Information - Chemocare
Drug Type: Decitabine is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Decitabine is classified as an antimetabolite and a ... https://chemocare.com Decitabine - PubMed
由 B Hackanson 著作 · 2014 · 被引用 37 次 — Besides 5-azacytidine (azacitidine, Vidaza®), 5-aza-2'-deoxycytidine (decitabine, Dacogen®) is the most widely used inhibitor of DNA methylation, ... https://pubmed.ncbi.nlm.nih.go Decitabine: An effective and safe treatment for ... - PubMed
由 X Feng 著作 · 2019 · 被引用 3 次 — However, the application of decitabine in myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) has not been fully examined. Thus, our study aimed ... https://pubmed.ncbi.nlm.nih.go Decitabine: Uses, Interactions, Mechanism of Action - DrugBank
Decitabine is a chemotherapeutic pyrimidine nucleoside analogue used for the treatment of myelodysplastic syndromes (MDS) by inducing DNA hypomethylation ... https://go.drugbank.com DACOGEN® (decitabine) for injection, for intravenous use
In preclinical studies in mice and rats, decitabine was teratogenic, fetotoxic, and embryotoxic. If this drug is used during pregnancy, or if a patient becomes ... https://www.accessdata.fda.gov Decitabine (5-Aza-2'-deoxycytidine) | DNMT Inhibitor
Decitabine (NSC 127716) is an orally active deoxycytidine analogue antimetabolite and a DNA methyltransferase inhibitor. Decitabine incorporates into DNA in ... https://www.medchemexpress.com |